Based on multi-step selection and validation, CHAF1B not only has a high diagnostic value in differentiating HCC patients from healthy controls but may also be a newly autophagy-related biomarker in HCC, which was significantly associated with the survival of HCC patients. Here, CHAF1B is linked to hepatocellular carcinoma.